Nokes Rachael 4
4 · scPharmaceuticals Inc. · Filed Aug 8, 2024
Insider Transaction Report
Form 4
Nokes Rachael
CFO and Treasurer
Transactions
- Exercise/Conversion
Common Stock
2024-08-06+10,445→ 72,851 total - Exercise/Conversion
Stock Option (right to buy)
2024-08-06−10,445→ 0 totalExercise: $1.66Exp: 2024-09-17→ Common Stock (10,445 underlying)
Footnotes (2)
- [F1]The option is fully vested.
- [F2]The number of options initially reported on the Reporting Person's February 28, 2019 Form 3 inadvertently overreported the number of options in Table II, column 3 by ten options. This Form 4 and the number of options reported in Table II, column 9 adjusts for the typographical error contained in the previously filed Form 3.